Antikor Competitors and Similar CompaniesClear all
Antikor's competitors and similar companies include SystImmune, Mersana Therapeutics, Dendreon and Legend Biotech.
 Antikor Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. |  Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. |  Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
| ||
Founding Date | Founding Date 2014 | Founding Date 2014 | Founding Date 2005 | Founding Date 1992 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Stevenage, GB HQ | Locations Redmond, US HQ | Locations Cambridge, US HQ | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US |
Employees | Employees 11 | Employees 841% increase | Employees 11033% increase | Employees 6131% decrease | Employees 2,90012% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 250.3 m | Valuation ($) N/A | Valuation ($) 8.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($69.2m) (FY, 2024) | Net income N/A | Net income ($296.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 76m | Total funding raised $ 219.5m | Total funding raised N/A | Total funding raised $ 150.5m |
For sources of this data, please see the company profile
View Company Profiles
SystImmune
HQ
Redmond, US
Employees
84↑ 1% increase
Systimmune is a biopharmaceutical company focused on the treatment of cancer.
View companyMersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View companyDendreon
HQ
Seal Beach, US
Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
View companyLegend Biotech
HQ
Somerset, US
Employees
2,900↑ 12% increase
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
View company